Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Fycompa 12mg tablets
0408010AKBBAFAF
|
Fycompa | Perampanel | Central Nervous System | 130 |
|
Primidone 50mg/5ml oral suspension
0408010U0AABABA
|
Primidone | Primidone | Central Nervous System | 130 |
|
Venzip XL 150mg capsules
0403040W0CEABAE
|
Venzip | Venlafaxine | Central Nervous System | 130 |
|
Zeyzelf 4.6mg/24hours twice weekly transdermal patches
0411000E0BLAAAF
|
Zeyzelf | Rivastigmine | Central Nervous System | 130 |
|
Eldepryl 10mg tablets
0409010T0BBABAC
|
Eldepryl | Selegiline hydrochloride | Central Nervous System | 129 |
|
Naltrexone 3mg capsules
0410030E0AAAIAI
|
Naltrexone hydrochloride | Naltrexone hydrochloride | Central Nervous System | 129 |
|
Renocontin 40mg modified-release tablets
0407020ADBRAFAH
|
Renocontin | Oxycodone hydrochloride | Central Nervous System | 129 |
|
Victanyl 25micrograms/hour transdermal patches
0407020A0BMAAAE
|
Victanyl | Fentanyl | Central Nervous System | 128 |
|
Apomorphine 30mg/3ml inj pre-filled disposable devices
0409010A0AAAXAX
|
Apomorph hydrochloride (Parkinsonism) | Apomorphine hydrochloride | Central Nervous System | 127 |
|
Renocontin 30mg modified-release tablets
0407020ADBRAEAR
|
Renocontin | Oxycodone hydrochloride | Central Nervous System | 127 |
|
Buprenorphine 8mg oral lyophilisates sugar free
0410030A0AAAMAM
|
Buprenorphine (Opioid Dependance) | Buprenorphine hydrochloride | Central Nervous System | 126 |
|
Cipralex 20mg/ml oral drops
0403030X0BBAEAF
|
Cipralex | Escitalopram | Central Nervous System | 126 |
|
Abtard 40mg modified-release tablets
0407020ADBMAEAH
|
Abtard | Oxycodone hydrochloride | Central Nervous System | 125 |
|
Clozapine 25mg tablets
0402010C0AAAAAA
|
Clozapine | Clozapine | Central Nervous System | 125 |
|
Exelon 13.3mg/24hours transdermal patches
0411000E0BBAHAI
|
Exelon | Rivastigmine | Central Nervous System | 125 |
|
Memantine 10mg soluble tablets sugar free
0411000G0AAAHAH
|
Memantine hydrochloride (Dementia) | Memantine hydrochloride | Central Nervous System | 125 |
|
Mirapexin 0.35mg tablets
0409010W0BBADAD
|
Mirapexin | Pramipexole | Central Nervous System | 124 |
|
Nicotinell Mint 4mg medicated chewing gum
0410020B0BCAGBD
|
Nicotinell | Nicotine | Central Nervous System | 123 |
|
Strattera 60mg capsules
0404000S0BBAEAE
|
Strattera | Atomoxetine hydrochloride | Central Nervous System | 123 |
|
Co-careldopa 25mg/100mg/5ml oral suspension
0409010N0AAAUAU
|
Co-careldopa | Co-careldopa (Carbidopa/levodopa) | Central Nervous System | 122 |
|
Molipaxin 150mg tablets
0403010X0BBADAD
|
Molipaxin | Trazodone hydrochloride | Central Nervous System | 122 |
|
Oxylan 40mg prolonged-release tablets (G.L. Pharma UK Ltd)
0407020ADBFADAH
|
Oxylan | Oxycodone hydrochloride | Central Nervous System | 122 |
|
Riluzole 50mg orodispersible films
0409030R0AAAEAE
|
Riluzole | Riluzole | Central Nervous System | 122 |
|
Solpadeine Plus capsules
0407010X0BMACA0
|
Solpadeine | Paracetamol combined preparations | Central Nervous System | 122 |
|
Nootropil 1200mg tablets
0409030P0BBACAC
|
Nootropil | Piracetam | Central Nervous System | 121 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.